argenx SE announced that during the extraordinary general meeting of shareholders held on 01 March 2023, Steve Krognes was appointed as a non-executive director to its Board of Directors. He will also become the chairperson of the Audit and Compliance Committee. As a result of the appointment of Mr. Krognes, Werner Lanthaler has formally resigned as non-executive director of the Board of Directors and chairperson of the Audit and Compliance Committee to enable this important step in long-term succession planning.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
352.5 EUR | -0.87% | +0.23% | +2.62% |
17/06 | Wedbush Adjusts Price Target on argenx to $519 From $521, Maintains Outperform Rating | MT |
13/06 | Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.62% | 22.66B | |
+16.45% | 122B | |
+19.15% | 113B | |
-16.26% | 21.34B | |
-39.57% | 16.92B | |
-13.99% | 16.68B | |
-16.29% | 16.61B | |
+3.15% | 13.62B | |
+21.93% | 11.04B | |
+109.17% | 10.43B |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx SE Appoints Steve Krognes to Board of Directors